Rater reliability of fragile X mutation size estimates: a multilaboratory analysis

Area of Science:

• Genetics
• Molecular Biology
• Clinical Diagnostics

Background:

• The fragile X (fra(X)) mutation, a leading cause of inherited intellectual disability, presents diagnostic challenges due to variable molecular manifestations.
• Inconsistent methodologies in describing and measuring fra(X) mutations across laboratories can lead to discrepancies in mutation size estimation.

Purpose of the Study:

• To evaluate the reliability and variability of fragile X mutation size estimation across different laboratories.
• To assess the impact of mutation appearance (band type) and size on estimation accuracy.

Main Methods:

• Genomic DNA was extracted from peripheral blood samples of individuals with known fra(X) mutations and unaffected controls.
• DNA fragments from four different laboratories were analyzed using Southern blot hybridization with the pE5.1 probe at a central facility.
• Blind evaluation of autoradiograph images was performed by raters to estimate mutation size.

Main Results:

• Raters' mutation size estimates showed favorable comparison with a reference test, indicating good accuracy.
• Intrarater reliability for mutation size estimation was consistently good to excellent.
• Variability in estimates was moderate and significantly correlated with both the absolute mutation size and the observed band type (discrete band, smear, mosaic).

Conclusions:

• Standardized protocols and central analysis can improve the consistency of fragile X mutation size estimation.
• Understanding the factors influencing variability, such as mutation size and band type, is crucial for accurate clinical interpretation.
• Further research may focus on refining molecular techniques to minimize inter-laboratory variation in fra(X) testing.